Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04614103
Title Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Iovance Biotherapeutics, Inc.
Indications

lung non-small cell carcinoma

Therapies

LN-145

Age Groups: senior | adult
Covered Countries USA | CAN

Additional content available in CKB BOOST